I find MLA a really interesting story which if you value on the current/past earnings is probably not appropriate.
I'm interested in what your assuming for basic metrics of sales growth and ongoing margin levels.
I've tried to do back of envelope calculations on what the most recent announcements mean and as I was calculating them I realised your correct that the nominal amounts of these are intially small (maybe a few hundred thousand dollars). But the addressable markets are huge and could be penetrated very quickly.
For example, the last UNICEF contract was for India only but given they appear to have worked with them for a year in developing the needle cutter to meet WHO standards and it was "head office" contracted you would expect more contracts from UNICEF will flow.
The opportunity for the burettes seems even larger if even just 1 hospital takes them up not just the ambulances.
What is apparent is this group is becoming or has become an OEM provider of choice.
I think the growth with surprise on the upside from the end of this year and then be ongoing.
MLA Price at posting:
33.0¢ Sentiment: LT Buy Disclosure: Held